In gastric cancer, CLDN4 was found to enhance the proliferation, invasion and epithelial-mesenchymal transition (EMT) of gastric cancer cells, and was reversed by miR-596 and miR-3620-3p [9]. The gene discussed is CLDN4; the disease is gastric cancer.